Maria Goulielmaki

BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells

Maria Goulielmaki, Evangelos Koustas, Eirini Moysidou et al. · Oncotarget · 2016 · 65 citations · Full text

Drug nanocarriers for cancer chemotherapy based on microemulsions: The case of Vemurafenib analog PLX4720

Ioanna Theochari, Maria Goulielmaki, Dganit Danino et al. · Colloids and Surfaces B Biointerfaces · 2017 · 36 citations

Nanoparticles, Nanomedicine, Vemurafenib Analog Plx4720 +11

Encapsulation of cannabidiol in oil-in-water nanoemulsions and nanoemulsion-filled hydrogels: A structure and biological assessment study

Sotiria Demisli, Eleni Galani, Maria Goulielmaki et al. · Journal of Colloid and Interface Science · 2022 · 36 citations · Full text

Biopolymer Gel, Hydrogels, Oil-in-water Nanoemulsions +8

Rational design of aqueous conjugated polymer nanoparticles as potential theranostic agents of breast cancer

Panagiota Korallı, Spyridon Tsikalakis, Maria Goulielmaki et al. · Materials Chemistry Frontiers · 2021 · 16 citations · Full text

Nanoparticles, Nanomedicine, Engineering +13

DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties

Maria Goulielmaki, Nikos Assimomytis, Jan Rožanc et al. · Translational Oncology · 2019 · 15 citations · Full text

Chemoprevention Strategy, Benzothiophene Nucleus, Kinase Inhibitors +20